The Herpes Simplex Virus Type 1 US7 Gene Product Is a 66K Glycoprotein and Is a Target for Complement-dependent Virus Neutralization
|
|
- Martina Robbins
- 6 years ago
- Views:
Transcription
1 J. gen. Virol. (1988), 69, Printed in Great Britain 859 Key words: HS V-1/vaccinia virus~us7 The Herpes Simplex Virus Type 1 US7 Gene Product Is a 66K Glycoprotein and Is a Target for Complement-dependent Virus Neutralization By VERONICA SULLIVAN AND GEOFFREY L. SMITH* Division of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, U.K. (Accepted 21 December 1987) SUMMARY The US7 open reading frame of herpes simplex virus type 1 (HSV-I), previously identified by nucleotide sequencing, has been expressed in a recombinant vaccinia virus (US7-VAC). Antiserum raised against HSV-1 reacted with a 66K glycoprotein in US7-VAC-infected cells and this polypeptide was present on both nuclear and cell surface membranes. In the presence of tunicamycin the protein was reduced in size to 58K showing it contained N-linked sugar residues. Antisera from animals vaccinated with US7-VAC recognized 66K and 58K polypeptides in HSV-l-infected cells and neutralized HSV-I infectivity in vitro in the presence of complement. INTRODUCTION Herpes simplex virus type 1 (HSV-1) is a large DNA virus which replicates in the nucleus of infected cells. The 155 kbp genome codes for at least seven membrane-associated glycoproteins (for reviews, see Spear, 1985; Marsden, 1987). These have been intensively studied since they are targets for antibody-mediated neutralization of virion infectivity and hence have potential as anti-hsv vaccines. Three of the glycoprotein genes map within the unique long (UL) region of the genome and are designated gb (Bzik et al., 1984; Pellet et al., 1985), gc (Frink et al., 1983) and gh (Buckmaster et al., 1984; McGeoch & Davison, 1986; Gompels & Minson, 1986). A further five open reading frames with glycoprotein characteristics were identified from the nucleotide sequence of the unique short (Us) region (McGeoch et al., 1985). Open reading frame US6 codes for gd (Spear, 1976), US8 for ge (Baucke & Spear, 1979) and US4 for gg (Ackermann et al., 1986; Richman et al., 1986; Frame et al., 1986; Sullivan & Smith, 1987) which has multiple forms in HSV-l-infected cells and virions. No product has yet been assigned to US5 but very recently US7 was shown to encode a 65K glycoprotein, designated gi (Longnecker et al., 1987). This protein may be the same as gp70 which appears to complex with ge to form the Fc receptor of HSV-l-infected cells (Johnson & Feenstra, 1987). Our approach to the identification of the US7 gene product was to express this open reading frame in recombinant vaccinia virus (US7-VAC). Serum raised against HSV-1 was used to identify the HSV protein in recombinant vaccinia virus-infected cells and antibody raised against the recombinant vaccinia virus was used to immunoprecipitate the US7 gene product from HSV-l-infected cells. Here we demonstrate that US7 encodes a 66K glycoprotein and show that it is present on the cell surface and nuclear membranes of US7-VAC-infected cells. In addition antibody raised against US7-VAC neutralizes HSV-1 infectivity in vitro in the presence of complement, demonstrating that the US7 gene product, gi, is a virion component. METHODS Cells and viruses. BHK-21 cells were passaged in Glasgow-modified Eagle's medium (GMEM) containing 10 tryptose phosphate broth and 10~ newborn calf serum. CV-I ceils and human thymidine kinase-negative (TK-) 143 cells were grown in GMEM supplemented with 10~ foetal bovine serum (FBS). HeLa $3 cells were O 1988 SGM
2 860 V. SULLIVAN AND G. L. SMITH maintained in suspension culture medium (Gibco) containing 5 ~ horse serum. HSV-1 strain SC 16 was grown and titrated in BHK cells. Vaccinia virus strain Western Reserve (WR) was grown in HeLa cells and titrated on CV-1 cells (Mackett et al., 1985). Construction of recombinant plasmid and vaccinia virus. A 1863 bp BamHI EcoRI DNA fragment containing the HSV-I strain Patton US7 gene was excised from plasmid psp64/us7 (Richman et al., 1986) and cloned into BamHI- and EcoRI-digested plasmid insertion vector pgs62 (Smith et al., 1987) downstream of the vaccinia virus promoter taken from a gene encoding a 7.5K protein. Recombinant plasmids were screened for a clone containing the correctly positioned US7 gene by restriction endonuclease digestion and agarose gel electrophoresis of minipreparations of DNA. The plasmid, called pvus7, was transfected into vaccinia virus-infected CV-1 cells and progeny virus was used to form plaques on TK- 143 cells in the presence of 25 p.g/ml bromodeoxyuridine. Plaques were screened for the presence of TK- recombinant virus containing the US7 gene inserted within the vaccinia virus TK gene by dot blot hybridization (Mackett et al., 1982) and a positive clone was plaque-purified and then grown and purified as described previously (Mackett et al., 1985). A pure recombinant vaccinia virus containing the US7 gene was called US7-VAC. Binding of antibody to vaccinia virus plaques. Plaques formed by recombinant US7-VAC or wild-type vaccinia virus (WT-VAC) on CV-1 cell monolayers were fixed with methanol and then incubated with rabbit antibody followed by 125i.labelled affinity-purified staphylococcal Protein A (Amersham) as described previously (Smith et al., 1983). Radioisotopic labelling and immune precipitation. BHK cells infected at an m.o.i, of 10 with HSV-1 (SC16) were incubated in reduced glucose medium (0.9 mg/ml) from 3.5 to 8 h post-infection and radiolabelled from 4 to 8 h post-infection with 60 ~tci/ml D-[1-1"C]glucosamine (60 mci/mmol; Amersham). Where indicated tunicamycin was added at 10 gg/ml 30 rain before, and during the labelling period. Lysates were prepared from infected cells and treated with antisera as previously described (Sullivan & Smith, 1987). Precipitated polypeptides were electrophoresed on 10~ polyacrylamide gels. Western blotting. BHK cells infected with WT-VAC or US7-VAC at 30 p.f.u./cell were harvested and lysed 16 h post-infection. Lysates were run on 10~ polyacrylamide gels and polypeptides transferred to nitrocellulose membranes as described (Sullivan & Smith, 1987). Membranes were incubated with, antisera followed by labelled affinity-purified Protein A. After washing and drying an autoradiograph was prepared. Immunofluorescence. CV-1 cells were grown on glass coverslips and infected with WT-VAC or US7-VAC. Sixteen h after infection cells were fixed in 5 ~ paraformaldehyde and, where indicated, permeabilized with 1 Triton X-100 (Randall et al., 1985). Hyperimmune rabbit anti-hsv-1 antibody, which had been preabsorbed on WT-VAC-infected cells for 20 h at 4 C, was added for l h at room temperature, followed by fluorescein isothiocyanate (FITC)-conjugated sheep anti-rabbit immunoglobulin (Wellcome). Photographs were taken under u.v. illumination at x 1000 magnification. In vitro neutralization of HSV-1 infectivity. Heat-inactivated pooled mouse sera were diluted in GMEM and mixed with 350 p.f.u, of HSV-1 strain SC16 for 30 min at 37 C. Then 2-5~ fresh or heat-inactivated complement was added and the mixture incubated at 37 C for a further 30 rain. Residual infectivity was assayed in duplicate on BHK cell monolayers. Cells were stained with toluidine blue 2 days later and plaques were counted. RESULTS The genome of recombinant vaccinia virus US7-VAC was analysed by restriction endonuclease digestion, agarose gel electrophoresis and Southern blotting. A 32p-labelled DNA fragment spanning the HSV-1 US7 open reading frame bound to the HindlII J fragment of recombinant virus US7-VAC but not WT-VAC. The HindllI J fragment of US7-VAC was also increased in size, consistent with the insertion of the vaccinia virus 7.5K promoter and US7 gene (data not shown). These data confirmed that US7-VAC had the predicted genome structure. Evidence for expression of the US7 gene in cells infected with US7-VAC was obtained by binding anti-hsv-1 antibody to plaques formed by the recombinant virus (Fig. 1). Anti-HSV-1 hyperimmune rabbit sera bound to plaques formed by US7-VAC but not by WT-VAC. Anti- HSV-2 antibody also recognized the US7-VAC but not WT plaques, demonstrating that the HSV-1 US7 gene product and the HSV-2 homologue (Hodgman & Minson, 1986; McGeoch et al., 1987) have type-common antigenic determinants. Both these anti-hsv sera also bound to a lesser extent to uninfected cells. As a control, rabbit anti-vaccinia virus antibody bound to both US7-VAC and WT-VAC plaques.
3 Identification of HSV-1 US7 gene product 861 Anti-VAC Anti-HSV-1 Anti-HSV-2 WT-VAC US7-VAC Fig. 1. Recognition of US7 antigen by anti-hsv-i and anti-hsv-2 sera. Plaques formed by recombinant US7-VAC or WT-VAC virus on CV-I cell monolayers were fixed with methanol and then incubated with the indicated rabbit antibodies followed by ~25I-labelled protein A. An autoradiograph is shown. Identification of the US7 gene product To identify the US7 polypeptide(s) expressed by recombinant vaccinia virus, lysates of cells infected with US7-VAC or WT-VAC were analysed by Western blotting using rabbit anti-hsv- 1 antibody (Fig. 2). Polypeptides of 66K and 58K were detected in US7-VAC-infected cells (arrowheads) but not in WT-VAC- or mock-infected cells. Preimmune rabbit sera did not react with these proteins. If the infection was carried out in the presence of tunicamycin, the 66K protein disappeared and the 58K form was the major species, indicating that the 66K form contains N-linked sugar residues. The reduced level of gi-specific polypeptides in the presence of tunicamycin could reflect decreased stability of the underglycosylated form, and/or reduced synthesis after prolonged incubation in the presence of this drug. Preimmune sera did not react with any polypeptides specific to US7-VAC-infected cells in the presence of tunicamycin. Cellular location of US7 protein The distribution of US7 proteins in US7-VAC-infected cells was examined by indirect immunofluorescence. Cells infected with US7-VAC or WT-VAC were incubated with rabbit anti-hsv-1 antibody followed by FITC-conjugated sheep anti-rabbit IgG (Fig. 3). If antibodies were reacted with cells with non-permeabilized surface membranes, HSV-1-specific antigen was detected on the surface of US7-VAC- but not WT-VAC-infected cells (panels a and b, respectively). In cells with permeabilized membranes (c and d) HSV-1 antigen was also detected strongly on the nuclear membrane and within the cytoplasm (c). Very little binding was observed on WT-VAC-infected cells (d). The US7-specified polypeptides are therefore transported to both the nuclear and cell surface membranes in the absence of other herpesvirus proteins. US7 protein in HSV-l-injected cells To detect the US7-specified polypeptide(s) in HSV-l-infected cells antibody was raised against US7 antigen by immunization of mice with US7-VAC. These sera were then used in immunoprecipitation assays using [14C]glucosamine-labelled HSV-l-infected cell lysates. A
4 862 V. SULLIVAN AND G. L. SMITH (a) (b) I i i i f 1 r M K ~, 69K ~, 66K 58K 46K D, Fig. 2. Western blot analysis of US7 gene product in US7-VAC-infected cells. CV-1 cell monolayers were mock-infected (lanes 1) or infected with WT-VAC (lanes 2) or US7-VAC (lanes 3) at 30 p.f.u./cell in the presence (+) or absence (-) of 10 Ixg/ml tunicamycin. Sixteen h later cell lysates were prepared and electrophoresed through a 10% polyacrylamide gel before transfer to nitrocellulose filters. Filters were incubated with either (a) rabbit anti-hsv-1 serum or (b) preimmune rabbit serum. Bound antibody was detected with 12SI-labelled protein A. An autoradiograph is shown. M, Mr markers. major band of 66K was immunoprecipitated from HSV-l-infected cells using mouse anti-us7- VAC sera but not mouse sera raised against another recombinant vaccinia virus (Fig. 4). Minor bands of 62K and 53K were also precipitated with the anti-us7 sera. In the presence of tunicamycin all bands disappeared. If [35S]methionine was used to radiolabel HSV-l-infected cells in the presence of tunicamycin a 58K band was detected with anti-us7 sera (data not shown). The US7 gene product is a target for antibody neutralization of virus Pooled antisera from ten mice immunized with recombinant vaccina virus US7-VAC or YC3- VAC were tested for their ability to neutralize HSV-1 infectivity in the presence of fresh or inactivated complement. Fig. 5 shows that antibody raised against US7-VAC was able to neutralize HSV-1 infectivity in the presence of complement but that sera raised against another TK- vaccinia virus recombinant expressing an unrelated gene were not. In the absence of fresh complement no virus neutralization was observed. The extent of neutralization was indistinguishable from that obtained in parallel with antisera raised against a vaccinia virus recombinant expressing HSV-1 gg (Sullivan & Smith, 1987). We had noted that anti-hsv-2 antibody reacted with plaques formed by US7-VAC and therefore were interested to know whether anti-us7-vac would neutralize HSV-2 infectivity. No neutralization was observed and we could not detect any HSV-2 polypeptides with anti-us7 serum (data not shown).
5 Identification of HSV-1 US7 gene product 863 (d) Fig. 3. Location of US7 gene product in US7-VAC-infected cells. Sixteen h after infection with WT- VAC (b, d) or US7-VAC (a, c) at 30 p.f.u./ceu, CV-1 cells were fixed in paraformaldehyde and then reacted with rabbit anti-hsv-1 serum either directly (a, b) or after permeabilization (c, d) with 1 Triton X-100. Bound antibody was detected with FITC-conjugated sheep anti-rabbit IgG. Photographs were taken using an oil immersion lens. Bar marker represents I0 I~m. DISCUSSION The open reading frame US7 of HSV-1, which was identified by nucleotide sequencing (McGeoch et al., 1985), has been expressed in recombinant vaccinia virus. The product of this gene is a 66K glycoprotein which associates with nuclear and cell surface membranes of infected cells and which contains N-linked carbohydrate. Consistent with this cellular location, the deduced amino acid sequence of the US7 gene contains hydrophobic amino acid sequences at the amino and carboxy termini which could function as membrane signal and anchor sequences, respectively. In addition the protein contains three potential N-linked carbohydrate attachment sites within the primary amino acid chain of Mr In the absence of N-linked carbohydrate we find the US7 gene product has an apparent Mr of 58K. Although this is considerably larger than the predicted primary translation product it is consistent with a 55K protein produced by in vitro translation of hybrid-selected RNA from the US7 region (Lee et al., 1982) and a 52K protein produced from in vitro translation of RNA transcribed from an SP6 vector containing the US7 gene (Richman et al., 1986). Recently the US7 gene product was identified in another way. Longnecker et al. (1987) constructed a mutant of HSV-1 from which US7 was deleted and identified a monoclonal antibody (Fd69) that reacted only with cells infected with viruses containing the US7 gene. Fd69 reacted with a 65K glycoprotein which was transported to the cell surface. Johnson & Feenstra
6 864 V. SULLIVAN AND G. L. SMITH K~ 66K 53K~ Fig. 4. Immunoprecipitation of US7 polypeptides from HSV-i-infected cell lysates. BHK cells were infected with HSV-1 and radiolabelled with [14C]glucosamine in the presence (lanes 2, 4) or absence (lanes 1, 3) of tunicamycin (see methods). Cell lysates were precipitated with pooled antisera from mice immunized with YC3-VAC (1, 2) or US7-VAC (3, 4) and radiolabelled proteins were electrophoresed on a 10~ polyacrylamide gel. The gel was fixed, impregnated with Amplify (Amersham), dried and an autoradiograph prepared. (1987) identified a 70K HSV-1 glycoprotein (designated g70) that is distinct from ge, gd and gg and which is probably encoded by US7. The g70 appears to complex with ge and form a receptor able to bind IgG. The product of the US7 open reading frame is the seventh glycoprotein shown to be encoded by the HSV-1 genome. Consistent with previous nomenclature this is called gi. The previous six virus-coded glycoproteins are all virion components and targets for virus neutralization by antibody (for review, see Marsden, 1987). Since antibody raised against gi neutralizes virus infectivity in vitro, gi must also be a virion component. Despite being virion components the majority of these virus-coded glycoproteins are not essential for virus replication in vitro, since viable mutants with deletions in gc, ge, gg, gi and the putative glycoprotein product of US5 have been constructed (Longnecker & Roizman, 1986, 1987; Weber et al., 1987; Longnecker et al., 1987). Regarding the functions of these non-essential glycoproteins, it is possible that they broaden cell tropism in vivo. Specifically, gg is reported to affect the virus pathogenesis in the central nervous system of mice (Weber et al., 1987). Glycoprotein E and a 70K glycoprotein which is probably gi interact to form the Fc receptor of HSV- 1-infected cells (Johnson & Feenstra, 1987).
7 Identification of HSV-1 US7 gene product I I I I I I (a) Z l I I I I I Dilution of sera Fig. 5. Neutralization of HSV-1 infectivity by anti-yc3-vac (O) and anti-us7-vac (0) antibody. Dilutions of heat-inactivated pooled mouse sera were incubated with 300 p.f.u, of HSV-I in the presence of (a) fresh or (b) heat-inactivated exogenous complement. Residual virus infectivity was assayed on BHK cell monolayers. Although the role in vivo of this complex is unclear it is possible that the Fc binding capacity of virions or infected cells is a mechanism helping evasion of membrane lysis by complementdependent antibody (Lehner et al., 1975 ; Frank & Friedman, 1987). If antibody bound to a virus glycoprotein either on the surface of an infected cell or virus particle were also complexed to the Fc receptor via the Fc region of the immunoglobulin, this might prevent complement binding and membrane lysis. Whatever the precise rote of gi is, it is apparent that it has a gene homologue in a colinear position of the HSV-2 genome (Hodgman & Minson, 1986; McGeoch et al., 1987) that is also immunologically cross-reactive. Varicella-zoster virus gpi and pseudorabies virus gp63 also have structural homology with HSV-1 gi (Davison, 1983 ; Davison et al., 1985, 1986; Davison & McGeoch, 1986; Petrovskis et al., 1986). These data suggest a conservation of function. Although we observed that antisera raised against HSV-2 recognize HSV-1 gi, serum raised against HSV-1 gi does not neutralize HSV-2 infectivity in vitro or react with HSV-2 proteins. This may be due to the relatively low titre or low avidity of antibody to HSV gi compared with the anti-hsv-2 antibody which was derived from a hyperimmunized rabbit. Although the neutralization of HSV-1 infectivity observed with anti-hsv-1 gi antibody is complementdependent and poor compared with that obtained with anti-gb, -gh or -gd antibodies, gi could have a role as a component of future anti-hsv-1 vaccines. In addition to its use in identifying HSV-1 gi, the recombinant vaccinia virus expressing gi will also be used to determine whether immunity to gi can prevent lethal or latent HSV-I infections in mice and whether T helper and T cytotoxic cells directed against the protein are produced during HSV-1 infection. We thank Tony Minson and Howard Marsden for helpful advice and Mary Wright for typing the manuscript. This work was supported by MRC grant and V.S. is the holder of a U.K. Medical Research Council Research Studentship
8 866 V. SULLIVAN AND G. L. SMITH REFERENCES ACKERMANN, M., LONGNECKER, R., ROIZMAN, B. & PEREIRA, L. (1986). Identification, properties and gene location of a novel glycoprotein specified by herpes simplex virus. 1. Virology 150, BAUCKE, R. B. & SVEAR, P. O. (1979). Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. Journal of Virology 32, BUCKMASTER, E. A., GOMPELS, U. & MINSON, A, (1984). Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 x 103 molecular weight. Virology 139, BZIK, D. J., FOX, B. A., DELUCA, N. A. & PERSON, S. (1984). Nucleotide sequence of a region of the herpes simplex virus type 1 gb glycoprotein gene: mutations affecting rate of virus entry and cell fusion. Virology 137, DAVISON, A. J. (1983). DNA sequence of the Us component of the varicella-zoster virus genome. EMBO Journal 2, DAVISON, A. J. & McGEOCH, D. J. (1986). Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. Journal of General Virology 67, DAVISON, A. J., WATERS, D. J. & EDSON, C. M. (1985). Identification of the products of a varicella-zoster virus glycoprotein gene. Journal of General Virology 66, DAVISON, A. J., EDSON, C. M., ELLIS, R. W., FORGHANI, B., GILDEN, D., GROSE, C., KELLER, P. M., VAFAI, A., WROBLEWSKA, Z. & YAMANISHI, K. (1986). New common nomenclature for glycoprotein genes of varicellazoster virus and their glycosylated products. Journal of Virology 57, FRAME, M. C., MA~SI)EN, H. S. & Mc~EOCtt, D. J. (1986). Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. Journal of General Virology 67, FRANK, L & FRIEI)MAN, H. M. (1987). Function of herpes simplex virus glycoprotein E. Clinical Research 35, 614A. FRINK, R. J., EISENBERG, R., COHEN, O. & WAONER, E. to. (1983). Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. Journal of Virology 45, OOMVELS, U. & MINSON, A. (1986). The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology 153, ODG~a~r~, T. C. & MINSON, A. C. (t986). The herpes simplex virus type 2 equivalent of the herpes simplex virus type 1 US7 gene and its flanking sequences. Virology 153, 1-I1. JOrINSON, D. c. & FEENSTe,~, V. (1987). Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with ge and binds immunoglobulin. Journal of Virology 61, LEE, G. T.-Y., Wd~A, M. F. & SPEAR, P. G. (1982). Location of the structural genes for glycoproteins D and E and for other polypeptides in the S component of the herpes simplex virus type 1 DNA. Journal of Virology 43, LEHNER, T., WILTON, J. M. A. & SHILLITOE, E. J. (1975). Immunological basis for latency, recurrences, and putative oncogenicity of herpes simplex virus. Lancet ii, LONGNECKER, R. & ROIZMAN, B. ([986). Generation of an inverting herpes simplex virus 1 mutant lacking the L-S junction a sequences, an origin of DNA synthesis, and several genes including those specifying glycoprotein E and the c~47 gene. Journal of Virology 58, LONGNECKER, R. & ROIZMAN, B. (1987). Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome. Science 236, LONGNEC~ER, R., ehatterjee, S., WnITLEV, R. J. & ROIZMAN, a. (1987). Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster disposable for growth in cell culture. Proceedings of the National Academy of Sciences, U.S.A, 84, 4303~4307. McGEOCH, D. J. & DAVISON, A. J. (1986). DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein H, and identification of homologues in the genomes of varieella-zoster and Epstein-Barr virus. Nucleic Acids Research 14, McGEOCH, D. J., DOLAN, A., DONALD, S. & RIXON, F. J. (1985). Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. Journal of Molecular Biology 181, McGEOCH, D. J., MOSS, H. W. M., McNAB, D. & FRAME, M. C. (1987). DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. Journal of General Virology 68, MACKETr, M., SMIrn, G. L. & MOSS, a. (1982). Vaccinia virus: a selective eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, U.S.A. 79, Y~CKETr, M., SMITa, ~. L. & MOSS, B. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach, pp Edited by D. M. Glover. Oxford & Washington, D.C. : IRL Press. MM~SDEN, H. S. (1987). Herpes simplex virus glycoproteins and pathogenesis. In Molecular Basis of Virus Disease, Society for General Microbiology Symposium 40, pp Edited by W. C. Russell & J. W. Almond. Cambridge: Cambridge University Press. PELLEr'r, P. E., KOUSOUL~, K. G., VEREIPO~, L. & ROIZMAN,'B. (1985). Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal resistant mutants. Journal of Virology 53, PETROVSKIS, E. A., TIMMINS, J. G. & IOST, L. E. (1986). Use of 2gtl 1 to isolate genes from two pseudorabies virus glycoproteins with homology to herpes simplex virus and varicella-zoster virus glycoproteins. Journal of Virology 60,
9 Identification of HSV-1 US7 gene product 867 RANDALL, R. E., NEWMAN, C. & lioness, R. W. (1985). Asynchronous expression of the immediate-early protein of herpes saimiri in populations of productively infected cells. Journal of General Virology 66, RICHMAN, D. D., BUCKMASTER, A., BELL, S., HODGMAN, C. & MINSON, A. C. (1986). Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. Journal of Virology 57, SMITH, G. L., MURPHY, B. R. & MOSS, B. (1983). Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza virus hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proceedings of the National Academy of Sciences, U.S.A. 80, SMITH, G. L., LEVIN, J., PALESE, P. & MOSS, B. (1987). Synthesis and cellular location of the ten influenza virus polypeptides individually expressed by recombinant vaccinia viruses. Virology 60, 33(~345. SPEAR, a. G. (1976). Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type-1 infected cells. Journal of Virology 17, SPEAR, P. G. (1985). Glycoproteins specified by herpes simplex virus. In The Herpesviruses, vol. 3, pp Edited by B. Roizman. New York: Plenum Press. SULLIVAN, V. & SMITH, G. L. (1987). Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gg) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gg antibody. Journal of General Virology 68, WEBER, P. C., LEVINE, M. & GLORIOSO, J. C. (1987). Rapid identification of non-essential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science 236, (Received 22 October 1987)
Plaque Size Phenotype as a Selectable Marker To Generate Vaccinia Virus Recombinants
JOURNAL OF VIROLOGY, Feb. 1989, p. 997-1001 0022-538X/89/020997-05$02.00/0 opyright 0 1989, American Society for Microbiology Vol. 63, No. 2 Plaque Size Phenotype as a Selectable Marker To Generate Vaccinia
More informationReceived 15 August 2006/Accepted 1 October 2006
JOURNAL OF VIROLOGY, Dec. 2006, p. 12312 12323 Vol. 80, No. 24 0022-538X/06/$08.00 0 doi:10.1128/jvi.01766-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Linker Insertion Mutations
More informationSANTA CRUZ BIOTECHNOLOGY, INC.
TECHNICAL SERVICE GUIDE: Western Blotting 2. What size bands were expected and what size bands were detected? 3. Was the blot blank or was a dark background or non-specific bands seen? 4. Did this same
More informationSerological Analysis of Herpes Simplex Virus Types 1 and 2
INFECTION AND IMMUNITY, Jan. 1982, p. 363-367 Vol. 35, No. 1 19-9567/82/1363-5$2./ Serological Analysis of Herpes Simplex Virus Types 1 and 2 with Monoclonal Antibodies LENORE PEREIRA,* DALE V. DONDERO,
More informationVaricella-Zoster Virus (VZV) ORF32 Encodes a Phosphoprotein That Is Posttranslationally Modified by the VZV ORF47 Protein Kinase
JOURNAL OF VIROLOGY, Oct. 1998, p. 8083 8088 Vol. 72, No. 10 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Varicella-Zoster Virus (VZV) ORF32 Encodes a Phosphoprotein
More informationChapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology
Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing
More informationApplication Note AN001
Testing hybridoma supernatants with the Spots On Dots Antibody Screening Kit Application Note AN1 Table of Contents Overview... 2 Figure 1. Screening of hybridomas raised against peptide antigens... 3
More informationDr: RAWIA BADR Associate Professor of Microbiology&Immunology
Dr: RAWIA BADR Associate Professor of Microbiology&Immunology Cell culture Commonly refers to the culture of animal cells and tissues, while the more specific term plant tissue.culture is used only for
More informationThe Role of Herpes Simplex Virus Type 1 Thymidine Kinase in Pathogenesis
J. gen. Virol. (1989), 70, 869-879. Printed in Great Britain 869 Key words: HSV/latency/thymidine kinase The Role of Herpes Simplex Virus Type 1 Thymidine Kinase in Pathogenesis By S. EFSTATHIOU, 1. S.
More informationRNA oligonucleotides and 2 -O-methylated oligonucleotides were synthesized by. 5 AGACACAAACACCAUUGUCACACUCCACAGC; Rand-2 OMe,
Materials and methods Oligonucleotides and DNA constructs RNA oligonucleotides and 2 -O-methylated oligonucleotides were synthesized by Dharmacon Inc. (Lafayette, CO). The sequences were: 122-2 OMe, 5
More information2054, Chap. 14, page 1
2054, Chap. 14, page 1 I. Recombinant DNA technology (Chapter 14) A. recombinant DNA technology = collection of methods used to perform genetic engineering 1. genetic engineering = deliberate modification
More informationThe 5 end problem. 3 5 Now what? RNA primers. DNA template. elongate. excise primers, elongate, ligate
1 2 3 DNA Replication Viruses must replicate their genomes to make new progeny This always requires expression of at least one virus protein, sometimes many (hence always delayed after infection) DNA is
More informationNeutralizing Monoclonal Antibodies Specific for Herpes Simplex
JOURNAL OF VIROLOGY, Nov. 1987, p. 3356-3364 0022-538X/87/113356-09$02.00/0 Copyright C) 1987, American Society for Microbiology Vol. 61, No. 11 Neutralizing Monoclonal Antibodies Specific for Herpes Simplex
More informationPresence of Herpes Simplex Virus-Related Antigens in
JOURNAL OF VIROLOGY, June 1975, p. 1475-1486 Copyright 1975 American Society for Microbiology Vol. 15, No. 6 Printed in U.S.A. Presence of Herpes Simplex Virus-Related Antigens in Transformed L Cells KAILASH
More informationBio 101 Sample questions: Chapter 10
Bio 101 Sample questions: Chapter 10 1. Which of the following is NOT needed for DNA replication? A. nucleotides B. ribosomes C. Enzymes (like polymerases) D. DNA E. all of the above are needed 2 The information
More information43). ge has Fc-binding activity (2, 24, 25). No activities have yet been associated with gg or gh. In one approach to characterizing the HSV VAC, we
JOURNAL OF VIROLOGY, Aug. 1985, p. 475-482 22-538X/85/8475-8$2./ Copyright 1985, American Society for Microbiology Vol. 55, No. 2 Specificities of Monoclonal and Polyclonal Antibodies That Inhibit Adsorption
More informationLecture Four. Molecular Approaches I: Nucleic Acids
Lecture Four. Molecular Approaches I: Nucleic Acids I. Recombinant DNA and Gene Cloning Recombinant DNA is DNA that has been created artificially. DNA from two or more sources is incorporated into a single
More informationEnhancers mutations that make the original mutant phenotype more extreme. Suppressors mutations that make the original mutant phenotype less extreme
Interactomics and Proteomics 1. Interactomics The field of interactomics is concerned with interactions between genes or proteins. They can be genetic interactions, in which two genes are involved in the
More informationImmunofluorescent detection of bovine papillomavirus E4 antigen in the cytoplasm of cells permissive in vitro for viral DNA amplification
Journal of General Virology (1991), 72, 2269-2274. Printed in Great Britain 2269 Immunofluorescent detection of bovine papillomavirus E4 antigen in the cytoplasm of cells permissive in vitro for viral
More informationIntroducing new DNA into the genome requires cloning the donor sequence, delivery of the cloned DNA into the cell, and integration into the genome.
Key Terms Chapter 32: Genetic Engineering Cloning describes propagation of a DNA sequence by incorporating it into a hybrid construct that can be replicated in a host cell. A cloning vector is a plasmid
More informationAntigenic Relationships among Autonomous Parvoviruses
J. gen. Virol. (1986), 67, 2839-2844. Printed in Great Britain 2839 Key words: antigenic relationships/autonomous parvoviruses Antigenic Relationships among Autonomous Parvoviruses ByW. L. MENGELING, l*
More informationFatchiyah
Fatchiyah Email: fatchiya@yahoo.co.id RNAs: mrna trna rrna RNAi DNAs: Protein: genome DNA cdna mikro-makro mono-poly single-multi Analysis: Identification human and animal disease Finger printing Sexing
More informationMolecular Cell Biology - Problem Drill 11: Recombinant DNA
Molecular Cell Biology - Problem Drill 11: Recombinant DNA Question No. 1 of 10 1. Which of the following statements about the sources of DNA used for molecular cloning is correct? Question #1 (A) cdna
More informationLearning Objectives :
Learning Objectives : Understand the basic differences between genomic and cdna libraries Understand how genomic libraries are constructed Understand the purpose for having overlapping DNA fragments in
More informationImmunoglobulins. Harper s biochemistry Chapter 49
Immunoglobulins Harper s biochemistry Chapter 49 Immune system Detects and inactivates foreign molecules, viruses, bacteria and microorganisms Two components with 2 strategies B Lymphocytes (humoral immune
More informationDeoxyribonucleoside Triphosphate Pools in Cells Infected with Deoxypyrimidine Kinaseless Herpes Simplex Virus
J. gen. ViroL (1976), 3 x, I~5-I23 Printed in Great Britain II5 Deoxyribonucleoside Triphosphate Pools in Cells Infected with Deoxypyrimidine Kinaseless Herpes Simplex Virus By A. T. JAMIESON* AND G. BJURSELL
More informationIssues in production of viral gene transfer vectors. Stefan Kochanek Department of Gene Therapy Ulm University
Issues in production of viral gene transfer vectors Stefan Kochanek Department of Gene Therapy Ulm University Only few positive results in gene therapy so far - many early phase, few late phase clinical
More informationRecombinant DNA Technology
Recombinant DNA Technology Common General Cloning Strategy Target DNA from donor organism extracted, cut with restriction endonuclease and ligated into a cloning vector cut with compatible restriction
More informationChapter 9 Genetic Engineering
Chapter 9 Genetic Engineering Biotechnology: use of microbes to make a protein product Recombinant DNA Technology: Insertion or modification of genes to produce desired proteins Genetic engineering: manipulation
More informationPractical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus
Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus Primary Source for figures and content: Tortora, G.J. Microbiology
More informationRecombinant DNA Technology. The Role of Recombinant DNA Technology in Biotechnology. yeast. Biotechnology. Recombinant DNA technology.
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University C H A P T E R 8 Recombinant DNA Technology The Role of Recombinant DNA Technology in Biotechnology Biotechnology?
More informationVZV Replication Assays Samantha J. Griffiths * and Jürgen Haas
VZV Replication Assays Samantha J. Griffiths * and Jürgen Haas Division of Pathway and Infection Medicine, University of Edinburgh, Edinburgh, UK *For correspondence: samantha.griffiths@ed.ac.uk [Abstract]
More information1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation?
1 Name MCB 150 Midterm Eam #1 (100 points total) Please write your full name on each page of the eam!! The eam consists of 17 questions (6 pages). Each has a different point count as indicated. Please
More informationMMG 301, Lec. 25 Mutations and Bacteriophage
MMG 301, Lec. 25 Mutations and Bacteriophage Questions for today: 1. What are mutations and how do they form? 2. How are mutant bacteria used in research? 3. What are the general properties of bacteriophage
More informationBiosafety and the NIH Guidelines
Biosafety and the NIH Guidelines This section will explore: Why the NIH Guidelines are important The definition of recombinant or synthetic nucleic acid research Content of the NIH Guidelines Section III
More information1 R01 AI IHD HALFORD, W
1 R01 AI108635-01 2 IHD 1R01AI108635-01 ILLIAM DESCRIPTION (provided by applicant): More than 20 years have been invested into the testing of herpes simplex virus 2 (HSV-2) subunit vaccines that contain
More informationDiscovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A
Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Contacts: Marty Simonetti martysimonetti@gmail.com Kirby Alton kirby.alton@abeomecorp.com Rick Shimkets
More information1 R01 AI VMD HALFORD, W
1 R01 AI104935-01 2 VMD 1R01AI104935-01 ILLIAM CRITIQUE 1: Significance: 5 Investigator(s): 2 Innovation: 5 Approach: 8 Environment: 2 Overall Impact: This application proposes to develop a recombinant
More informationGLENN RANDALL, MICHAEL LAGUNOFF*, AND BERNARD ROIZMAN
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 10379 10384, September 1997 Microbiology The product of ORF O located within the domain of herpes simplex virus 1 genome transcribed during latent infection binds
More informationElectrophoresis and transfer
Electrophoresis and transfer Electrophoresis Cation = positively charged ion, it moves toward the cathode (-) Anion = negatively charged ion, it moves toward the anode (+) Amphoteric substance = can have
More informationSecretory Immunoglobulin A and Herpes Keratitis
INFECTION AND IMMuNrnr, Dec. 1970, p. 778-782 Copyright 1970 American Society for Microbiology Vol. 2, No. 6 Printed in U.S.A Secretory Immunoglobulin A and Herpes Keratitis Y. M. CENTIFANTO AND H. E.
More informationBy R. W. HONESS,* K. L. POWELL t, D. J. ROBINSON,~ CAROLINE SIM AND D. H. WATSON
J. gen. ViroL 0974), 22, I59-~69 Printed in Great Britain I59 Type Specific and Type Common Antigens in Cells Infected with Herpes Simplex Virus Type 1 and on the Surfaces of Naked and Enveloped Particles
More informationRole of Cellular Phosphatase cdc25c in Herpes Simplex Virus 1 Replication
JOURNAL OF VIROLOGY, May 2008, p. 4527 4532 Vol. 82, No. 9 0022-538X/08/$08.00 0 doi:10.1128/jvi.02021-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Role of Cellular Phosphatase
More informationShutoff of Protein Synthesis Induced by Activated Protein Kinase R and Partially Restores Neurovirulence
JOURNAL OF VIROLOGY, Feb. 2002, p. 942 949 Vol. 76, No. 3 0022-538X/02/$04.00 0 DOI: 10.1128/JVI.76.3.942 949.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved. Second-Site Mutation
More informationSynthetic Biology for
Synthetic Biology for Plasmids and DNA Digestion Plasmids Plasmids are small DNA molecules that are separate from chromosomal DNA They are most commonly found as double stranded, circular DNA Typical plasmids
More informationab G alpha i Activation Assay Kit
ab173234 G alpha i Activation Assay Kit Instructions for Use For the simple and fast measurement of G alpha i activation. This product is for research use only and is not intended for diagnostic use. Version
More informationThe gh-gl Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge
JOURNAL OF VIROLOGY, Jan. 1998, p. 65 72 Vol. 72, No. 1 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology The gh-gl Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody
More informationBiotechnology. Chapter 20. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 20 Biotechnology PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright
More informationGenetics Lecture 21 Recombinant DNA
Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of
More informationSupporting Information
Supporting Information Su et al. 10.1073/pnas.1211604110 SI Materials and Methods Cell Culture and Plasmids. Tera-1 and Tera-2 cells (ATCC: HTB- 105/106) were maintained in McCoy s 5A medium with 15% FBS
More informationMOLECULAR GENETICS: TRANSFORMATION AND CLONING adapted by Dr. D. L. Vogelien
Introduction MOLECULAR GENETICS: TRANSFORMATION AND CLONING adapted by Dr. D. L. Vogelien The field of molecular genetics has resulted in a number of practical applications that have been of tremendous
More informationGene Expression Technology
Gene Expression Technology Bing Zhang Department of Biomedical Informatics Vanderbilt University bing.zhang@vanderbilt.edu Gene expression Gene expression is the process by which information from a gene
More informationCHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? CHAPTER 2A STUDENT GUIDE 2013 Amgen Foundation. All rights reserved.
CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? 35 INTRODUCTION In the Program Introduction, you learned that the increase in diabetes in the United States has resulted in a great demand for its treatment,
More informationThe Region of the Herpes Simplex Virus Type 1 LAT Gene That Is Colinear with the ICP34.5 Gene Is Not Involved in Spontaneous Reactivation
JOURNAL OF VIROLOGY, Jan. 1996, p. 282 291 Vol. 70, No. 1 0022-538X/96/$04.00 0 Copyright 1996, American Society for Microbiology The Region of the Herpes Simplex Virus Type 1 LAT Gene That Is Colinear
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Veterinary Use CVMP/IWP/07/98-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES
More informationCHAPTER 9 DNA Technologies
CHAPTER 9 DNA Technologies Recombinant DNA Artificially created DNA that combines sequences that do not occur together in the nature Basis of much of the modern molecular biology Molecular cloning of genes
More informationmcherry Polyclonal Antibody Catalog Number PA Product data sheet
Website: thermofisher.com Customer Service (US): 1 800 955 6288 ext. 1 Technical Support (US): 1 800 955 6288 ext. 441 mcherry Polyclonal Antibody Catalog Number PA5-34974 Product data sheet Details Size
More informationnumber Done by Corrected by Doctor Hamed Al Zoubi
number 3 Done by Neda a Baniata Corrected by Waseem Abu Obeida Doctor Hamed Al Zoubi Note: it is important to refer to slides. Bacterial genetics *The main concepts we will talk about in this lecture:
More informationPotential Role for Herpes Simplex Virus ICP8 DNA Replication Protein in Stimulation of Late Gene Expression
JOURNAL OF VIROLOGY, May 1991, p. 2666-2675 0022-538X/91/052666-10$02.00/0 Copyright 1991, American Society for Microbiology Vol. 65, No. 5 Potential Role for Herpes Simplex Virus ICP8 DNA Replication
More informationEquine Herpesvirus 1 Glycoprotein D: Mapping of the Transcript and a Neutralization Epitope
JOURNAL OF VIROLOGY, Nov. 1992, p. 6451-6460 0022-538X/92/116451-10$02.00/0 Copyright 1992, American Society for Microbiology Vol. 66, No. 11 Equine Herpesvirus 1 Glycoprotein D: Mapping of the Transcript
More informationASPP1 Fw GGTTGGGAATCCACGTGTTG ASPP1 Rv GCCATATCTTGGAGCTCTGAGAG
Supplemental Materials and Methods Plasmids: the following plasmids were used in the supplementary data: pwzl-myc- Lats2 (Aylon et al, 2006), pretrosuper-vector and pretrosuper-shp53 (generous gift of
More informationAURELIA A. HALLER,* TESSA MILLER, MISRACH MITIKU, AND KATHLEEN COELINGH Aviron, Mountain View, California 94043
JOURNAL OF VIROLOGY, Dec. 2000, p. 11626 11635 Vol. 74, No. 24 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Expression of the Surface Glycoproteins of Human
More informationAntibody Structure. Antibodies
Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against
More informationAntibody Structure supports Function
Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against
More informationProblem Set 8. Answer Key
MCB 102 University of California, Berkeley August 11, 2009 Isabelle Philipp Online Document Problem Set 8 Answer Key 1. The Genetic Code (a) Are all amino acids encoded by the same number of codons? no
More informationOrigin of Thymidine Kinase in Adenovirus-Infected Human Cell Lines
JOURNAL OF VIROLOGY, Apr. 1970, p. 446-450 Copyright ( 1970 American Society for Microbiology Vol. 5, No. 4 Printed in U.S.A. Origin of Thymidine Kinase in Adenovirus-Infected Human Cell Lines SAUL KIT,
More informationLecture 25 (11/15/17)
Lecture 25 (11/15/17) Reading: Ch9; 328-332 Ch25; 990-995, 1005-1012 Problems: Ch9 (study-guide: applying); 1,2 Ch9 (study-guide: facts); 7,8 Ch25 (text); 1-3,5-7,9,10,13-15 Ch25 (study-guide: applying);
More informationENCODE DCC Antibody Validation Document
ENCODE DCC Antibody Validation Document Date of Submission 09/12/12 Name: Trupti Kawli Email: trupti@stanford.edu Lab Snyder Antibody Name: SREBP1 (sc-8984) Target: SREBP1 Company/ Source: Santa Cruz Biotechnology
More informationMultiple choice questions (numbers in brackets indicate the number of correct answers)
1 Multiple choice questions (numbers in brackets indicate the number of correct answers) February 1, 2013 1. Ribose is found in Nucleic acids Proteins Lipids RNA DNA (2) 2. Most RNA in cells is transfer
More informationSelf-test Quiz for Chapter 12 (From DNA to Protein: Genotype to Phenotype)
Self-test Quiz for Chapter 12 (From DNA to Protein: Genotype to Phenotype) Question#1: One-Gene, One-Polypeptide The figure below shows the results of feeding trials with one auxotroph strain of Neurospora
More informationName 10 Molecular Biology of the Gene Test Date Study Guide You must know: The structure of DNA. The major steps to replication.
Name 10 Molecular Biology of the Gene Test Date Study Guide You must know: The structure of DNA. The major steps to replication. The difference between replication, transcription, and translation. How
More informationSolutions to Quiz II
MIT Department of Biology 7.014 Introductory Biology, Spring 2005 Solutions to 7.014 Quiz II Class Average = 79 Median = 82 Grade Range % A 90-100 27 B 75-89 37 C 59 74 25 D 41 58 7 F 0 40 2 Question 1
More informationMany viruses can use multiple alternative receptors for cell
Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage Miri Yoon and Patricia G. Spear* Department of Microbiology Immunology,
More informationTotal Test Questions: 71 Levels: Grades Units of Credit: 1.0 STANDARD 1 STUDENTS WILL INVESTIGATE THE PAST, PRESENT, AND FUTURE APPLICATIONS OF
DESCRIPTION Biotechnology is designed to create an awareness of career possibilities in the field of biotechnology. Students are introduced to diagnostic and therapeutic laboratory procedures that support
More informationab Ran Activation Assay Kit
ab173247 Ran Activation Assay Kit Instructions for Use For the simple and fast measurement of Ran activation. This product is for research use only and is not intended for diagnostic use. Version 1 Last
More informationGenome research in eukaryotes
Functional Genomics Genome and EST sequencing can tell us how many POTENTIAL genes are present in the genome Proteomics can tell us about proteins and their interactions The goal of functional genomics
More informationGenetics - Problem Drill 19: Dissection of Gene Function: Mutational Analysis of Model Organisms
Genetics - Problem Drill 19: Dissection of Gene Function: Mutational Analysis of Model Organisms No. 1 of 10 1. The mouse gene knockout is based on. (A) Homologous recombination (B) Site-specific recombination
More informationTamako KATO,1 Kenichi KITAMURA,1 Yasuhiko HAYAKAWA,1. Michiaki TAKAHASHI,1 Asato KOJIMA,2 Shigeo SATO,2. and Koichi YAMANISHI*,1
Microbiol. Immunol. Vol. 33 (4), 299-312, 1989 Transcription Mapping of Glycoprotein I (gpi) and gpiv of Varicella-Zoster Virus and Immunological Analysis of the gpi Produced in Cells Infected with the
More informationThe Biotechnology Education Company. Quantitative ELISA. Storage: See Page 3 for specific storage instructions EXPERIMENT OBJECTIVE:
The Biotechnology Education Company Revised and Updated Quantitative ELISA Storage: See Page 3 for specific storage instructions EXPERIMENT OBJECTIVE: EDVO-Kit # 278 The objective of this experiment is
More informationChapter 10 Analytical Biotechnology and the Human Genome
Chapter 10 Analytical Biotechnology and the Human Genome Chapter Outline Enzyme tests and biosensors DNA-based tests DNA analysis technologies Human genome and genome-based analytical methods 1 Enzyme-based
More informationAntibodies to Animal Cells and Serum Proteins
ANTIBODIES TO ANIMAL CELLS AND SERUM PROTEINS Antibodies to Animal Cells and Serum Proteins Antibodies to Animal Cellular Antigens Antibodies to Mouse Brain Antibodies to Animal Serum Proteins INTERNATIONAL
More informationSerology as a Diagnostic Technique
Serology as a Diagnostic Technique Characteristics of Any Diagnostic Techniques Any useful detection strategy must be: Specific: yield a positive response for only the target organism or molecule. Sensitive:
More informationImmunochemical Characterization of Pyrimidine Kinase Induced by VariceUa-Zoster Virus
J. gen. Virol. (1985), 66, 221 229. Printed in Great Britain 221 Key words: VZV/thymidine kinase/deoxycytidine kinase Immunochemical Characterization of Pyrimidine Kinase Induced by VariceUa-Zoster Virus
More informationWestern-GUARANTEED Antibody Service FAQ
Western-GUARANTEED Antibody Service FAQ Content Q 1: When do I need a Western GUARANTEED Peptide Antibody Package?...2 Q 2: Can GenScript provide a Western blot guaranteed antibody?...2 Q 3: Does GenScript
More informationMicrobial Biotechnology agustin krisna wardani
Microbial Biotechnology agustin krisna wardani 1. The Structure of Microbes Microbes (microorganisms) are tiny organisms that are too small to be seen individually by the naked eye and must be viewed with
More informationWesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits
WesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits Code N221-KIT N220-KIT Description WesternMAX Chemiluminescent AP Kit, Anti-Mouse Includes: Alkaline Phosphatase (AP) Conjugated Anti-Mouse
More informationMolecular Genetics Student Objectives
Molecular Genetics Student Objectives Exam 1: Enduring understanding 3.A: Heritable information provides for continuity of life. Essential knowledge 3.A.1: DNA, and in some cases RNA, is the primary source
More informationConstruction and Properties of a Cell Line Constitutively Expressing
JOURNAL OF VIROLOGY, Nov. 1986, p. 674-682 Vol. 60, No. 2 0022-538X/86/110674-09$02.00/0 Copyright C) 1986, American Society for Microbiology Construction and Properties of a Cell Line Constitutively Expressing
More informationTechnical tips Session 5
Technical tips Session 5 Chromatine Immunoprecipitation (ChIP): This is a powerful in vivo method to quantitate interaction of proteins associated with specific regions of the genome. It involves the immunoprecipitation
More informationSynthetic Biology. Sustainable Energy. Therapeutics Industrial Enzymes. Agriculture. Accelerating Discoveries, Expanding Possibilities. Design.
Synthetic Biology Accelerating Discoveries, Expanding Possibilities Sustainable Energy Therapeutics Industrial Enzymes Agriculture Design Build Generate Solutions to Advance Synthetic Biology Research
More informationThe Surface Nature of Proteins of a Bovine Enterovirus, Before and After Neutralization
J. gen. ViroL (976), 32, 17-23 Printed in Great Britain 17 The Surface Nature of Proteins of a Bovine Enterovirus, Before and After Neutralization By P. CARTHEW* Department of Biochemistry, Queen's University
More informationApoTrack Cytochrome c Apoptosis ICC Antibody
ab110417 ApoTrack Cytochrome c Apoptosis ICC Antibody Instructions for Use For the Immunocytochemistry analysis of cytochrome c and a mitochondrial marker (Complex Vα) in apoptotic cells and nonapoptotic
More informationSulphated Glycoproteins Induced by Herpes Simplex Virus
J. gen. Virol. (1982), 58, 399-415. Printed in Great Britain 399 Key words: HSV/glycoproteins/sulphation/gene mapping Sulphated Glycoproteins nduced by Herpes Simplex Virus By R. G. HOPE, J. PALFREYMAN,
More informationof Nebraska - Lincoln
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Papers in Veterinary and Biomedical Science Veterinary and Biomedical Sciences, Department of 1997 Phosphorylation within
More informationGenetic Engineering & Recombinant DNA
Genetic Engineering & Recombinant DNA Chapter 10 Copyright The McGraw-Hill Companies, Inc) Permission required for reproduction or display. Applications of Genetic Engineering Basic science vs. Applied
More informationBA, BSc, and MSc Degree Examinations
Examination Candidate Number: Desk Number: BA, BSc, and MSc Degree Examinations 2017-8 Department : BIOLOGY Title of Exam: Genetics Time Allowed: 1 hour and 30 minutes Marking Scheme: Total marks available
More informationLECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to:
LECTURE: 22 Title IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to: Identify the chromosome that contains the gene segments that encode the surface immunoglobulin heavy chain
More informationCHAPTER 20 DNA TECHNOLOGY AND GENOMICS. Section A: DNA Cloning
Section A: DNA Cloning 1. DNA technology makes it possible to clone genes for basic research and commercial applications: an overview 2. Restriction enzymes are used to make recombinant DNA 3. Genes can
More informationRoche Molecular Biochemicals Technical Note No. LC 10/2000
Roche Molecular Biochemicals Technical Note No. LC 10/2000 LightCycler Overview of LightCycler Quantification Methods 1. General Introduction Introduction Content Definitions This Technical Note will introduce
More information